CareDx (CDNA) Tops Q3 EPS by 51c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. RTX
8. SMCI
9. S
10. COF

Go back to CareDx (CDNA) Tops Q3 EPS by 51c

CareDx Reports Third Quarter 2016 Financial Results

November 9, 2016 4:01 PM EST

BRISBANE, Calif., Nov. 09, 2016 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today reported financial results for the third quarter ended September 30, 2016.

Recent highlights:

Achieved total revenue for the third quarter of 2016 of $12.5M, up 74% year-over-year AlloMap® revenues were $8.6M in the quarter, with US tests volume up by 6% year-over-yearOlerup® revenues contributed $3.8M in the third quarter Launched Olerup... More